ABCA3 and alkaline phosphatase measurement: The identification of GTCPF-related biomarkers, such as ARHGAP32 and ABCA3, which are correlated with immune cell infiltration and disease severity, indicates potential approaches for early diagnosis and personalized treatment options for patients with AP.